Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Rank in Stocks #41419
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Share Price
$0.0001
Last synced: 2025-06-11
Market Cap
$21.52K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CA
Trade Diagnocure, Inc. (DGCRF)

Category

Price of DGCRF with the market cap of B
Diagnocure, Inc. Diagnocure, Inc.
DGCRF
$0.0001
Market Capitalization of Diagnocure, Inc.(DGCRF)
Market Cap: $21.52K
As of August 2026 Diagnocure, Inc. has a market cap of $21.52K. This makes Diagnocure, Inc. the world's 41419th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Diagnocure, Inc. from 2012 to 2026
DGCRF compared with Top 5 Most Popular stocks
Price of DGCRF Asset B Mkt. of B Results
Diagnocure, Inc. Diagnocure, Inc.
$25,015.61 $21.52K
$5.383T +25,015,610,773.61%
Diagnocure, Inc. Diagnocure, Inc.
$20,554.79 $21.52K
$4.423T +20,554,791,738.93%
Diagnocure, Inc. Diagnocure, Inc.
$19,332.57 $21.52K
$4.160T +19,332,571,457.07%
Diagnocure, Inc. Diagnocure, Inc.
$17,022.87 $21.52K
$3.663T +17,022,866,242.94%
Diagnocure, Inc. Diagnocure, Inc.
$13,435.08 $21.52K
$2.891T +13,435,077,945.54%